Epaned Kit Patent Expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8778366 AZURITY Enalapril compositions
Nov, 2032

(8 years from now)

US8568747 AZURITY Enalapril compositions
Nov, 2032

(8 years from now)

US9855214 AZURITY Enalapril compositions
Nov, 2032

(8 years from now)

US9968553 AZURITY Enalapril compositions
Nov, 2032

(8 years from now)



Epaned Kit is a drug owned by Azurity Pharmaceuticals Inc. It is used for treating left ventricular dysfunction and heart failure. Epaned Kit uses Enalapril Maleate as an active ingredient. Epaned Kit was launched by Azurity in 2013. It is is available in for solution form for oral use. Its generic launch date based on the expiry of its last outstanding patent is estimated to be Nov 06, 2032 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using ENALAPRIL MALEATE ingredient

Market Authorisation Date: 13 August, 2013

Treatment: Method of treating left ventricular dysfunction; Treatment of heart failure

Dosage: FOR SOLUTION

How can I launch a generic of EPANED KIT before it's drug patent expiration?
More Information on Dosage

EPANED KIT family patents

Family Patents